AVI Polymers Officially Launches Ashwini.tech Health AI Platform Under SEBI Regulation 30
AVI Polymers Limited has officially launched its flagship Ashwini.tech health AI platform on April 30, 2026, ahead of schedule, completing its dual-engine AI strategy alongside exceptional FY26 financial performance. The platform features comprehensive healthcare tools including OCR extraction, medical timelines, and family health records, positioning the company in the high-growth HealthTech and AgriTech markets with multiple revenue streams planned for commercialization.

*this image is generated using AI for illustrative purposes only.
AVI Polymers Limited has officially launched its flagship personal healthcare AI platform, Ashwini.tech (AVI Health AI), completing the foundational build-out of its dual-engine AI strategy. The announcement was made on April 30, 2026, under Regulation 30 of the SEBI (LODR) Regulations, 2015, with the platform now live and operational at ashwini.tech. This launch comes ahead of the previously targeted May 3, 2026, date and follows the company's exceptional FY26 financial performance.
Official Regulatory Announcement
The Board of Directors announced that the flagship personal-healthcare AI platform is now officially live and operational, developed by wholly-owned tech subsidiary AVI Health AI. The platform brings a paradigm shift to India's digital healthcare ecosystem, engineered specifically for India's mobile-first generation. The successful launch ahead of schedule completes the dual-tech ecosystem alongside the already live and scaling KrishiBuddy agritech platform, positioning AVI Polymers at the intersection of India's fastest-growing digital markets: AgriTech and HealthTech.
| Launch Details | Information |
|---|---|
| Platform Name | Ashwini.tech (AVI Health AI) |
| Launch Date | April 30, 2026 |
| Target Date | May 3, 2026 |
| Regulatory Filing | SEBI Regulation 30 |
| Developer | AVI AI Technologies Private Limited |
| Website | ashwini.tech |
FY26 Financial Performance
The company's audited financial results for the year ended March 31, 2026, demonstrate a complete business transformation. Revenue from operations expanded dramatically to ₹312.11 crore from ₹0.06 crore in FY25, while net profit after tax increased 24.9 times to ₹20.33 crore compared to ₹0.82 crore in the previous fiscal year. The company successfully completed a ₹89.99 crore rights issue during FY26, which was fully subscribed by shareholders, strengthening its balance sheet with net worth of ₹115.99 crore and cash and cash equivalents of ₹16.60 crore.
| Financial Metric | FY26 | FY25 | Growth |
|---|---|---|---|
| Revenue from Operations | ₹312.11 Cr | ₹0.06 Cr | Complete reset |
| Total Income | ₹312.59 Cr | ₹1.38 Cr | 226x |
| Profit Before Tax | ₹27.73 Cr | ₹1.09 Cr | 25.4x |
| Net Profit After Tax | ₹20.33 Cr | ₹0.82 Cr | 24.9x |
| Net Worth | ₹115.99 Cr | ₹5.67 Cr | 20.5x |
| Earnings Per Share | ₹2.16 | ₹2.00 | +8% |
Comprehensive Platform Capabilities
Developed by wholly-owned subsidiary AVI AI Technologies Private Limited, Ashwini.tech is engineered specifically for India's mobile-first generation. The platform features six integrated instruments including The Reader for OCR and clinical extraction, The Timeline for source-linked medical history, Explain My Lab for plain-English explanations, Medication Brain for adherence tracking, Doctor Pack for printable visit summaries, and The Household for family profiles with role-aware caregiver access. The platform is currently live in private beta with conversational AI capabilities powered by Llama on Groq, providing sub-second responses with verifiable citations.
| Platform Features | Functionality |
|---|---|
| The Reader | OCR + clinical extraction for English & Indian languages |
| The Timeline | Chronological, source-linked medical history |
| Explain My Lab | Plain-English explanations grounded in user trends |
| Medication Brain | Schedules, adherence, refills tracking |
| Doctor Pack | One-page printable visit summary |
| The Household | Family profiles with role-aware caregiver access |
Strategic Market Positioning
Ashwini.tech operates in the Personal Health Records (PHR) segment, positioned in the high stickiness, low competition quadrant of the market landscape. The platform leverages three key tailwinds: the Ayushman Bharat Digital Mission with 670 million+ ABHA accounts and 420 million+ records linked, 825 million+ internet users with sub-₹0.20/GB data costs, and the demographic opportunity of the sandwich generation aged 35-55 managing both parents and children. The company's zero-debt balance sheet and recent capital infusion provide flexibility for commercialization and ecosystem monetization in FY27.
Multi-Engine Revenue Strategy
The platform operates on a comprehensive revenue model with consumer subscriptions planned for general availability launch, NRI premium caregiving services targeting the diaspora market within 6-12 months, Doctor Pack channels for hospital and clinic OPD partnerships in Year 2, insurance white-label solutions and ABDM gateway services in Years 2-3, and pharma real-world evidence cohorts from Year 3 onwards. The same data layer feeds each revenue engine, enabling incremental revenue without incremental cost. The company maintains a risk-conscious design with a "no diagnosis, ever" pact, ensuring the platform serves as an information aid rather than clinical decision support.
Historical Stock Returns for AVI Polymers
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.99% | +33.85% | +13.14% | +50.49% | +40.24% | +100.10% |
How will AVI Polymers compete with established healthcare platforms like Practo and 1mg in the crowded Indian digital health market?
What regulatory challenges might Ashwini.tech face as it scales, particularly around data privacy and healthcare compliance in India?
Can AVI Polymers successfully monetize both AgriTech and HealthTech platforms simultaneously, or will resource allocation become a strategic challenge?


































